[Management of patients with hepatitis C virus infection. Virological tests].
Pawlotsky
Jean-Michel
JM
Laboratoire de Virologie (EA 3489), Hôpital Henri-Mondor, Université Paris XII, Créteil.
D000208:Acute Disease; D000328:Adult; D000465:Algorithms; D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015415:Biomarkers; D002213:Capsid / Q000276:immunology; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D015658:HIV Infections / Q000150:complications; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis* / Q000628:therapy / Q000635:transmission / Q000821:virology*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000175:diagnosis* / Q000628:therapy / Q000821:virology*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008991:Monitoring, Physiologic; D016133:Polymerase Chain Reaction; D011379:Prognosis; D012367:RNA, Viral / Q000032:analysis; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D019562:Viral Load
D000914:Antibodies, Viral; D000956:Antigens, Viral; D000998:Antiviral Agents; D015415:Biomarkers; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons